Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Unknown 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Neoplasms 2013Carcinoma, Non-Small-Cell Lung 1228Breast Neoplasms 1215Leukemia, Myeloid, Acute 969Neoplasm Metastasis 903Melanoma 778Colorectal Neoplasms 752Multiple Myeloma 725Lymphoma 725Ovarian Neoplasms 675Pancreatic Neoplasms 665Prostatic Neoplasms 659Lymphoma, Non-Hodgkin 659Recurrence 637Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Lung Neoplasms 561Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 528Leukemia 486Lymphoma, Large B-Cell, Diffuse 441Lymphoma, Follicular 420Brain Neoplasms 415Squamous Cell Carcinoma of Head and Neck 389Stomach Neoplasms 388Carcinoma, Renal Cell 385Myelodysplastic Syndromes 382Carcinoma, Hepatocellular 368Advanced Solid Tumors 358Lymphoma, Mantle-Cell 345Glioma 344

Interventions

nimotuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Advanced and/or Metastatic Solid Tumours × Clear all
NCT05836623 2024-02-28

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Crescendo Biologics Ltd.

Phase 1 Unknown
5 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT04839991 2023-11-18

POTENTIA

Crescendo Biologics Ltd.

Phase 1 Unknown
70 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT00369252 2007-02-28

Phase I Study of Nimotuzumab in Solid Tumours

YM BioSciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡